Publications by authors named "Aino Launonen"

Claim this Profile
U
US cost-effectiveness analysis of polatuzumab vedotin in previously untreated diffuse large B-cell lymphoma.
Matthew Matasar, Anthony Masaquel, Rodrigo S Ho, Aino Launonen, Carmen D Ng

J Med Econ· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of statistical methods for extrapolating survival in previously untreated diffuse large B-cell lymphoma: results based on the POLARIX study.
Rodrigo S Ho, Aino Launonen

J Med Econ· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Approximation of Long-Term Survival with Polatuzumab Vedotin Plus Bendamustine and Rituximab for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results Based on The GO29365 Trial.
F Felizzi, Aino Launonen, P-O Thuresson

Pharmacoecon Open· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Approximation of Long-Term Survival with Polatuzumab Vedotin Plus Bendamustine and Rituximab for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results Based on The GO29365 Trial.
F Felizzi, Aino Launonen, P-O Thuresson

Pharmacoecon Open· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Factors for and Outcomes of Follicular Lymphoma Histological Transformation at First Progression in the GALLIUM Study.
Carla Casulo, Michael Herold, Wolfgang Hiddemann, Sunil Iyengar, Robert E Marcus, Aino Launonen

Clin Lymphoma Myeloma Leuk· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Relapse in First-Line Follicular Lymphoma: A Review of the Clinical Implications and Available Mitigation and Management Strategies.
Thomas D Rodgers, Carla Casulo, Frederic Boissard, Aino Launonen, Joana Parreira

Oncol Ther· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III Clinical Trials in First-Line Follicular Lymphoma: A Review of Their Design and Interpretation.
Emmanuel Bachy, Kaspar Rufibach, Joana Parreira, Aino Launonen, Tina Nielsen

Adv Ther· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of obinutuzumab versus rituximab biosimilars for previously untreated follicular lymphoma.
Scott J Spencer, Gregory F Guzauskas, Federico FeLizzi, Aino Launonen, Keith Dawson

J Manag Care Spec Pharm· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The societal impact of obinutuzumab in the first-line treatment of patients with follicular lymphoma in Germany.
Sarah Hofmann, Sebastian Himmler, Dennis Ostwald, Ulrich Dünzinger, Aino Launonen

J Comp Eff Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression.
John F Seymour, Robert Marcus, Andrew Davies, Eve Gallop-Evans, Andrew Grigg, Aino Launonen

Haematologica· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression.
John F Seymour, Robert Marcus, Andrew Davies, Eve Gallop-Evans, Andrew Grigg, Aino Launonen

Haematologica· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life and symptoms in patients with rituximab-refractory indolent non-Hodgkin lymphoma treated in the phase III GADOLIN study with obinutuzumab plus bendamustine versus bendamustine alone.
Bruce D Cheson, Peter C Trask, John G Gribben, Natalie Dimier, Eva Kimby, Aino Launonen

Ann Hematol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The single dose pharmacokinetic profile of a novel oral human parathyroid hormone formulation in healthy postmenopausal women.
Sibylle P Hämmerle, Linda Mindeholm, Aino Launonen, Beate Kiese, Rolf Loeffler

Bone· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of the levonorgestrel-releasing intrauterine system and breast cancer.
Tiina Backman, Ilkka Rauramo, Kimmo Jaakkola, Pirjo Inki, Katja Vaahtera, Aino Launonen

Obstet Gynecol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis